RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment [Yahoo! Finance]
RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment
RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement [Yahoo! Finance]
RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement
RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET [Yahoo! Finance]